Department of Cardiology, St George's Hospital, London, UK.
Clin Chem. 2012 Jan;58(1):219-25. doi: 10.1373/clinchem.2011.171082. Epub 2011 Nov 18.
We sought to determine the effect of patient selection on the 99th reference percentile of 2 sensitive and 1 high-sensitivity (hs) cardiac troponin assays in a well-defined reference population.
Individuals>45 years old were randomly selected from 7 representative local community practices. Detailed information regarding the participants was collected via questionnaires. The healthy reference population was defined as individuals who had no history of vascular disease, hypertension, or heavy alcohol intake; were not receiving cardiac medication; and had blood pressure<140/90 mmHg, fasting blood glucose<110 mg/dL (approximately 6 mmol/L), estimated creatinine clearance>60 mL·min(-1)·(1.73 m2)(-1), and normal cardiac function according to results of echocardiography. Samples were stored at -70 °C until analysis for cardiac troponin I (cTnI) and cardiac troponin T (cTnT) and N-terminal pro-B-type natriuretic peptide.
Application of progressively more stringent population selection strategies to the initial baseline population of 545 participants until the only individuals who remained were completely healthy according to the study criteria reduced the number of outliers seen and led to a progressive decrease in the 99th-percentile value obtained for the Roche hs-cTnT assay and the sensitive Beckman cTnI assay but not for the sensitive Siemens Ultra cTnI assay. Furthermore, a sex difference found in the baseline population for the hs-cTnT (P=0.0018) and Beckman cTnI assays (P<0.0001) progressively decreased with more stringent population selection criteria.
The reference population selection strategy significantly influenced the 99th percentile reference values determined for troponin assays and the observed sex differences in troponin concentrations.
我们旨在确定在明确的参考人群中,患者选择对 2 种敏感和 1 种高敏(hs)心脏肌钙蛋白检测的第 99 个参考百分位的影响。
从 7 个有代表性的社区实践中随机选择>45 岁的个体。通过问卷收集有关参与者的详细信息。健康参考人群被定义为没有血管疾病、高血压或大量饮酒史的个体;未接受心脏药物治疗的个体;血压<140/90mmHg、空腹血糖<110mg/dL(约 6mmol/L)、估计肌酐清除率>60mL·min-1·(1.73 m2)-1和根据超声心动图结果正常的心脏功能的个体。样品在-70°C 下储存,直到分析心脏肌钙蛋白 I(cTnI)和心脏肌钙蛋白 T(cTnT)和 N 末端 pro-B 型利钠肽。
将逐渐更严格的人群选择策略应用于最初的 545 名参与者的基线人群中,直到根据研究标准仅剩下完全健康的个体,这减少了观察到的异常值的数量,并导致罗氏 hs-cTnT 检测和敏感贝克曼 cTnI 检测的第 99 个百分位值逐渐降低,但敏感西门子 Ultra cTnI 检测则不然。此外,在基线人群中发现 hs-cTnT(P=0.0018)和贝克曼 cTnI 检测(P<0.0001)的性别差异随着更严格的人群选择标准而逐渐减小。
参考人群选择策略显著影响了肌钙蛋白检测的第 99 个百分位参考值和观察到的肌钙蛋白浓度的性别差异。